UK (Parliament Politics Magazine) – Big drug companies have paused £2bn in UK investments, blaming low drug pricing support, as job cuts and industry unrest deepen. As reported by The Guardian, major pharmaceutical firms have scrapped or stalled nearly £2bn in UK